Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease

British Journal of Haematology

Volumn 126, Issue 5, 2004, Pages 736-742

  Voskaridou, Ersi ^a   Douskou, Maroussa ^b   Terpos, Evangelos ^c   Papassotiriou, Ioannis ^d   Stamoulakatou, Alexandra ^e   Ourailidis, Akis ^b   Loutradi, Aphroditi ^a   Loukopoulos, Dimitris ^f  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b BIOIATRIKI HEALTHCARE GROUP   (Greece)

^c General Airforce Hospital   (Greece)

^d Department of Clinical Biochemistry ^*  (Greece)

^e AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^f BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Beta thalassaemia; Iron overload; Magnetic resonance imaging; Sickle cell disease

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADULT; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HEART CONTRACTION; HEART LEFT VENTRICLE EJECTION TIME; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; SICKLE CELL ANEMIA;

ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; BLOOD TRANSFUSION; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; STATISTICS, NONPARAMETRIC;

EID: 4544301060     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05104.x     Document Type: Article

References (27)

1. Aldouri, M.A., Wonke, B., Hoffbrand, A.V., Flynn, D.M., Ward, S.E., Agnew, J.E. & Hilson, A.J. (1990) High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusion and iron chelation: Reversal by intensified chelation. Acta Haematologica, 84, 113-117.
2. Anderson, L.J., Holden, S., Davis, B., Prescott, E., Charrier, C.C., Bunce, N.H., Firmin, D.N., Wonke, B., Porter, J., Walker, J.M. & Pennell, D.J. (2001) Cardiovascular T2-star (T2Black star) magnetic resonance for the early diagnosis of myocardial iron overload. European Heart Journal, 22, 2171-2179.
3. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Piga, A., Di Gregorio, F., Gamberini, M.R., Sabato, V., Melevendi, C., Cappellini, M.D. & Verlato, G. (1988) Survival and disease complications in thalassemia major. Annals of New York Academy of Science, 850, 227-231.
4. Brittenham, G.M., Farrell, D.E., Harris, J.W., Feldman, E.S., Danish, E.H., Muir, W.A., Tripp, J.H. & Bellon, E.M. (1982) Magnetic susceptibility measurement of human iron stores. New England Journal of Medicine, 307, 1671-1675.
5. Brittenham, G.M., Griffith, P.M., Nienhuis, A.W., McLaren, C.E., Young, N.S., Tucker, E.E., Allen, C.J., Farrell, D.E. & Harris, J.W. (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. New England Journal of Medicine, 331, 567-573.
6. Brown, D.W., Henkelman, R.M., Poon, P.Y. & Fisher, M.M. (1985) Nuclear magnetic resonance study of iron overload in liver tissue. Magnetic Resonance Imaging, 3, 275-282.
7. Brownell, A., Lowson, S. & Brozovic, M. (1986) Serum ferritin concentration in sickle crisis. Journal of Clinical Pathology, 39, 253-255.
8. Buja, L.M. & Roberts, W.C. (1971) Iron in the heart. American Journal of Medicine, 51, 209-221.
9. Fischer, R. (1998) Liver iron susceptometry. In: Magnestism in Medicine: A Hand-Book (ed. by W. Andra & H. Nowak), pp. 286-301. Wiley-VCH, Berlin.
10. Fischer, R., Longo, F., Nielsen, P., Engelhardt, R., Hider, R.C. & Piga, A. (2003) Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. British Journal of Haematology, 121, 938-948.
11. Gandon, Y., Olivie, D., Guyader, D., Aube, C., Oberti, F., Sebille, V. & Deugnier, Y. (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet, 363, 357-362.
12. Gomori, J.M., Horev, G., Tamary, H., Zandback, J., Kornreich, L., Zaizov, R., Freud, E., Krief, O., Ben-Meir, J. & Rotem, H. (1991) Hepatic iron overload: quantitative MR imaging. Radiology, 179, 367-379.
13. Hoffbrand, A.V. (2003) A sensitive test for early myocardial iron loading. European Heart Journal, 24, 26-27.
14. In den Kleef, J.J. & Cuppen, J.J. (1987) RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magnetic Resonance in Medicine, 5, 513-524.
15. Jensen, P.D., Jensen, F.T., Christensen, T. & Ellegaard, J. (1994) Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. British Journal of Haematology, 87, 171-184.
16. Jensen, P.D., Jensen, F.T., Christensen, T., Heickendorff, L., Jensen, L.G. & Ellegaard, J. (2001) Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA, 12, 153-166.
17. Kaltwasser, J.P.G.R., Schalk, K.P. & Hartl, W. (1990) Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. British Journal of Haematology, 74, 360-363.
18. Mavrogeni, S.I., Maris, T., Gouliamos, A., Vlahos, L. & Kremastinos, D.T. (1998) Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging. International Journal of Cardiac Imaging, 14, 117-122.
19. Nitz, W.R. (2002) Fast and ultrafast non-echo-planar MR imaging techniques. European Radiology, 12, 2866-2882.
20. Olivieri, N.F. & Brittenham, G.M. (1997) Iron-chelating therapy and the treatment of thalassemia. Blood, 89, 739-761.
21. Olivieri, N.F., Brittenham, G.M., Matsui, D., Berkovitch, M., Blendis, L.M., Cameron, R.G., McClelland, R.A., Liu, P.P., Templeton, D.M. & Koren, G. (1995) Iron chelation therapy with oral deferiprone in patients with thalassemia major. New England Journal of Medicine, 332, 918-922.
22. Ooi, G.C., Khong, P.L., Chan, G.C., Chan, K.N., Chan, K.L., Lam, W., Ng, I. & Ha, S.Y. (2004) Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. British Journal of Haematology, 124, 385-390.
23. Porter, J.B. & Davis, B.A. (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassemia. Best Practice and Research in Clinical Haematology, 15, 329-368.
24. Prieto, J., Barry, M. & Sherlock, S. (1975) Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology, 68, 525-533.
25. Villeneuve, J.P., Bilodeau, M., Lepage, R., Cote, J. & Lefebvre, M. (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. Journal of Hepatology, 25, 172-177.
26. Vogel, M., Anderson, L.J., Holden, S., Deanfield, J.E., Pennel, D.J. & Walker, J.M. (2003) Tissue Doppler echocardiography in patients with thalassemia detects early myocardial dysfunction related to myocardial iron overload. European Heart Journal, 24, 113-119.
27. Vymazal, J., Urgosik, D. & Bulte, J.W. (2000) Differentiation between hemosiderin- and ferritin-bound brain iron using nuclear magnetic resonance and magnetic resonance imaging. Cellular and Molecular Biology, 46, 835-842.